AMHERST, Mass., Sept. 15, 2017 /Weed Wire/ — As Massachusetts prepares to begin sales of recreational marijuana in 2018, researchers at the University of Massachusetts Amherst School of Public Health and Health Sciences (SPHHS), in collaboration with the UMass Donahue Institute and staff at the state Department of Public Health (DPH), have begun a one-year baseline study to assess the level of marijuana use before legal, recreational sales go into effect.
Tag Archives: Study
From gluts to labeling updates and the combination of medical and recreational sectors, the Washington cannabis market has been on a rollercoaster ride, but flower has managed to remain king of the hill.
On Sept. 7, 2017, Gov. Phil Scott signed Executive Order 15-17, officially launching the Vermont Marijuana Advisory Commission. The commission will explore several options concerning how to successfully legalize recreational marijuana in the state.
The “gateway theory,” the theory that cannabis use leads to the use of harder drugs, has been debunked once again by academia.
NEW PALTZ, NY, Sept. 8, 2017 /Weed Wire/ — The Benjamin Center for Public Policy Initiatives at SUNY New Paltz has released its 18th discussion brief, “The Marijuana Gateway Fallacy.” The brief marshals extensive social science evidence to show that the idea that marijuana use is a “gateway” to the use of harder drugs is a myth.
Washington recreational cannabis sales and diversion rates took a dip when neighboring Oregon enacted recreational legalization.
Washington has one more statistic to support the legalization of recreational cannabis in the Evergreen State: Washington youth cannabis use hasn’t increased since the enactment of Initiative 502, the measure that legalized recreational cannabis in the state.
On Aug. 6, 2017, Sue Sisley, M.D., sent a letter to Secretary of Veterans Affairs David Shulkin to request that he stop a Phoenix hospital’s obstruction of the first clinical trial to study the effects of medical cannabis in the treatment of post-traumatic stress disorder in military veterans.
Research into the potential medical uses of marijuana compounds continues apace. Among the most recent, a study delved into why marijuana is an effective stress reducer.
OTTAWA, Ontario, Aug. 28, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF) and Altasciences are pleased to share that they are in the final stages of completing the world’s first safety and tolerability study on a cannabis extract being developed as a new chemical entity for approval by the FDA and Health Canada as a drug.
The possibility of Tennessee medical marijuana legalization has been given new hope with a recent announcement from state lawmakers.
Marijuana use has little to no effect on kidney function in healthy young adults. This is according to a new study published in the Clinical Journal of the American Society of Nephrology on Aug, 24, 2017.
NEW YORK, Aug. 24, 2017 /Weed Wire/ — The National Institute of Health has awarded a $3.8 million research grant to Albert Einstein College of Medicine and Montefiore Health System for medical marijuana research, and Vireo Health of New York will be partners in the study.
Smoking marijuana may reduce your risk of having a stroke, according to a new study published in the journal Neuropsychopharmacology.
People who smoke marijuana have a three times greater risk of dying from hypertension, or high blood pressure, than those who have never used the drug, scientists said on Wednesday.
On Aug. 8, 2017, Albert Einstein College of Medicine and Montefiore Health System announced that they had received a grant from the National Institutes of Health to conduct a long-term study on how medical cannabis affects opioid use in adults with chronic pain.
Zynerba Pharmaceuticals Inc said on Monday its synthetic cannabis-based gel to treat epilepsy failed a mid-stage study, sending the U.S. drug developer’s shares plunging 50 percent.
The NFL has written to the NFL Players Association offering to work in tandem to study the potential use of marijuana as a pain management tool for players, according to people familiar with the situation.
Colorado’s legal recreational cannabis sales commenced in 2014, but not every municipality chose to embrace the retail market, so a Colorado Springs retail cannabis market has yet to materialize; however, some citizens are looking to change that.
Marijuana arrests in the Old Dominion State disproportionately affect black communities, but reform could be on the horizon—officials have launched a Virginia marijuana decriminalization study and they want to hear from the public.
WASHINGTON, July 25, 2017 /Weed Wire/ — On July 25, Representatives Andy Harris, M.D. (R-MD-01), Earl Blumenauer (D-OR-03), H. Morgan Griffith (R-VA-09), and Zoe Lofgren (D-CA-19) introduced the Medical Marijuana Research Act of 2017.
Cannabis may be California’s largest cash crop, but dispensaries who sell the profitable plants haven’t always reaped their rewards.
An often held assumption about medical marijuana dispensaries is that they are a magnet for drugs, violence and crime; however, a new study in the Journal of Urban Economics turns that assumption on its head.
SALT LAKE CITY, Utah, June 27, 2017 /Weed Wire/ — A February poll of 402 Utahns found that 73% of voters support a medical cannabis ballot initiative, with only 20% opposed and 7% undecided.
DENVER, June 23, 2017 /Weed Wire/ — The Cannabis Business Alliance (CBA) has released a statement in response to a recent insurance study by the Highway Loss Data Institute (HLDI) linking the legalization of recreational marijuana with an increase in car crashes reported to insurers.
DENVER, June 23, 2017 /Weed Wire/ —The Cannabis Business Alliance (CBA) has released a statement in response to a recent insurance study by the Highway Loss Data Institute (HLDI) linking the legalization of recreational marijuana with an increase in car crashes reported to insurers.
A new study finds an increase in accident insurance claims in three marijuana states that have approved the sale of cannabis for recreational use.
While Pennsylvania is processing hundreds of medical cannabis business applications, one private Pennsylvanian research university is already making plans to conduct a medical cannabis autism study.
In this Cal Can Biz interview, watch Caroline Cahill, Managing Editor of http://www.MJINews.com and Marijuana Industry News magazine, interview Mara Gordon, founder of Aunt Zelda’s.
As the Golden State prepares to roll out new medical and recreational regulations on Jan. 1, 2018, a recent California cannabis study has estimated that all of that preparation will result in a $5 billion windfall for the state’s legal market.
The combination of cannabinoids and chemotherapy could be the key to improving cancer treatment. This is according to a new study published in the International Journal of Oncology on May 29, 2017.
A new cannabis study published in the New England Journal of Medicine saw a nearly 40 percent drop in seizures for participants who were using the marijuana derivative called cannabidiol.
Researchers with Washington State University are looking for individuals to volunteer for a marijuana breathalyzer study. According to The Spokesman-Review, the study is attempting to determine if a marijuana breathalyzer can actually register “acute exposure” to THC.
The marijuana industry, and marijuana stock investors for that matter, have been expanding by leaps and bounds over the past two decades. One good way to keep this up is through university-based clinical studies. Studies like these really fan the flame of what might be possible with cannabis-based medicines.
While there’s nothing quite like enjoying the fruits of a marijuana farmer’s labor, that labor doesn’t come without potential hazards to those who work the land.
On May 16, 2017, the Minnesota Department of Health announced that a recent study shows a majority of patients enrolled in the Minnesota Medical Cannabis Program have reported medical cannabis benefitting their conditions.
ST. PAUL, Minn., May 16, 2017 /Weed Wire/ — A majority of Minnesota patients using medical cannabis reported benefits during the first year of the program, according to early data from a first-of-its-kind study by the Minnesota Department of Health (MDH).
When it comes to marijuana enforcement, it’s no secret that racial disparities persist even though black and white communities use marijuana at similar rates. The most recent reminder of this comes from the Old Dominion State, where Virginia marijuana arrests continue to disproportionately affect black communities.
According to a recent study published in the journal Natural Medicine, marijuana may help protect aging brains from cognitive decline.
Can this prolonged low-dose treatment with a compound in marijuana help reverse memory loss and improve cognitive skills? Researchers say it could.
On May 3, 2017, the Maryland Office of Legislative Audits released a fiscal compliance audit of the state’s regulatory services, including an examination of the Maryland Medical Cannabis Commission’s contracting of Towson University’s Regional Economic Studies Institute to process and evaluate applications for cultivation, processing and dispensing.
ANNAPOLIS, Md., April 27, 2017 /Weed Wire/ – Governor Larry Hogan today directed the Governor’s Office of Minority Affairs (GOMA) to initiate a disparity study of Maryland’s regulated medical cannabis industry.
A new report published in Health Affairs found that if all states had legalized medical marijuana in 2014, Medicaid could have saved $1 billion in spending on prescriptions.
On March 29, 2017, researchers at the University of British Columbia’s Michael Smith Laboratories announced that they have identified the cannabis genes responsible for producing terpenes, the plant’s aroma-producing compounds.
PHOENIX, March 17, 2017 /Weed Wire/ — As of March 15, 2017, five participants have received marijuana (cannabis) provided by the National Institute on Drug Abuse (NIDA) in an ongoing Phase 2 clinical trial sponsored by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) at the Scottsdale Research Institute (SRI) in Phoenix, Ariz. MAPS is committed to sponsoring rigorous clinical research to develop cannabis into a prescription medicine through the Food and Drug Administration (FDA).
SAN FRANCISCO, March 14, 2017 /Weed Wire/ — Enlucem, a strategic brand consultancy currently advising startups in the cannabis space, announced today the results of a detailed consumer study of Californians’ attitudes toward cannabis products.
According to a study recently published by the International Journal of Drug Policy, patients in Canada are substituting marijuana for opioids, benzodiazepines and antidepressants for symptom relief from pain and mental health conditions.
DENVER, Feb. 23, 2017 /Weed Wire/ — The Cannabis Business Alliance (CBA) has released a statement regarding recent comments from the White House on adult-use marijuana.
In mid-February, researchers at Colorado State University and the Center for Health, Work & Environment at the Colorado School of Public Health, published “Work and Well-Being in the Colorado Cannabis Industry.”
On Feb. 6, 2017, the first clinical trial to study the effects of medical marijuana in the treatment of post-traumatic stress disorder in military veterans dispensed medical marijuana to its first veteran at the Scottsdale Research Institute in Phoenix.